A detailed history of Israel Englander (Millennium Management LLC) transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,954,085 shares of ABOS stock, worth $6.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,954,085
Previous 2,629,541 25.69%
Holding current value
$6.31 Million
Previous $10.6 Million 55.6%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.14 - $4.01 $1.45 Million - $2.71 Million
-675,456 Reduced 25.69%
1,954,085 $4.73 Million
Q1 2024

May 15, 2024

BUY
$2.97 - $4.64 $3.37 Million - $5.26 Million
1,134,257 Added 75.86%
2,629,541 $10.6 Million
Q4 2023

Feb 14, 2024

BUY
$1.86 - $4.48 $649,634 - $1.56 Million
349,266 Added 30.48%
1,495,284 $5.74 Million
Q2 2023

Aug 14, 2023

BUY
$3.59 - $6.59 $1.8 Million - $3.3 Million
500,135 Added 77.43%
1,146,018 $5.51 Million
Q1 2023

May 15, 2023

SELL
$3.75 - $6.65 $74,373 - $131,889
-19,833 Reduced 2.98%
645,883 $2.62 Million
Q4 2022

Feb 14, 2023

BUY
$4.81 - $10.17 $939,027 - $1.99 Million
195,224 Added 41.49%
665,716 $3.6 Million
Q3 2022

Nov 14, 2022

SELL
$4.44 - $10.48 $519,884 - $1.23 Million
-117,091 Reduced 19.93%
470,492 $4.72 Million

Others Institutions Holding ABOS

About Acumen Pharmaceuticals, Inc.


  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $131M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.